REVIEW
H1N1 infection and embolic events A multifaceted disease
More details
Hide details
1
6th Respiratory Dept., “Sotiria” Hospital for Thoracic Diseases, Athens, Greece
Corresponding author
Ioannis Dimitroulis
6th Respiratory Dept.,
“Sotiria” Hospital for Thoracic Diseases
152 Mesogeion Ave, Athens, GR-115 27, Greece
Pneumon 2016;29(3):230-235
KEYWORDS
ABSTRACT
H1N1 infection which affects a large number of people globally, is mainly regarded as a disease that affects the lung parenchyma. H1N1 infection is a multifaceted disease that beyond affecting the lung parenchyma, it affects the pulmonary vasculature as well. Even beyond this, it affects the vasculature in other parts of the body (either arteries or veins), and can cause other embolic events not strictly falling in the “usual” thrombotic category. This review, the first on this subject, tries to bring to focus what is known in the literature up to now, raise the awareness about the complications of the H1N1 disease, and alert the various medical specialties involved in the treatment of this multifaceted disease. These embolic events occur mostly (but not only) during pandemics.
ACKNOWLEDGEMENTS
The author has no relevant affiliations or financial
involvement with any organization or entity related to the
subject of this review. No writing assistance was utilized
in the production of this manuscript.
REFERENCES (33)
1.
Centers for Disease C, Prevention. Outbreak of swine-origin influenza A (H1N1) virus infection - Mexico, March-April 2009. MMWR Morbidity and mortality weekly report 2009; 58:467-70.
2.
Novel Swine-Origin Influenza AVIT, Dawood FS, Jain S, et al. Emergence of a novel swine-origin influenza A (H1N1) virus in humans. N Engl J Med 2009; 360:2605-15.
3.
Agarwal PP, Cinti S, Kazerooni EA. Chest radiographic and CT findings in novel swine-origin influenza A (H1N1) virus (S-OIV) infection. AJR Am J Roentgenol 2009; 193:1488-93.
4.
Avnon LS, Munteanu D, Smoliakov A, Jotkowitz A, Barski L. Thromboembolic events in patients with severe pandemic influenza A/H1N1. Eur J Intern Med 2015; 26:596-8.
5.
Harms PW, Schmidt LA, Smith LB, et al. Autopsy findings in eight patients with fatal H1N1 influenza. Am J Clin Pathol 2010; 134:27-35.
6.
Kumar A, Zarychanski R, Pinto R, et al. Critically ill patients with 2009 influenza A(H1N1) infection in Canada. JAMA 2009; 302:1872-9.
7.
Ohrui T, Takahashi H, Ebihara S, Matsui T, Nakayama K, Sasaki H. Influenza A virus infection and pulmonary microthromboembolism. The Tohoku journal of experimental medicine 2000; 192:81-6.
8.
van Wissen M, Keller TT, Ronkes B, et al. Influenza infection and risk of acute pulmonary embolism. Thrombosis Journal 2007; 5:16.
9.
Citton R, Del Borgo C, Belvisi V, Mastroianni CM. Pandemic influenza H1N1, legionellosis, splenic rupture, and vascular thrombosis: a dangerous cocktail. J Postgrad Med 2012; 58:228-9.
10.
Davison AM, Thomson D, Robson JS. Intravascular coagulation complicating influenza A virus infection. Br Med J 1973; 1:654-5.
11.
Emmerich J. Infection and venous thrombosis. Pathophysiology of haemostasis and thrombosis 2002; 32:346-8.
12.
Miyashita T, Shimamoto Y, Nishiya H, et al. Destructive pulmonary embolism in a patient with community-acquired staphylococcal bacteremia. Journal of infection and chemotherapy: Official Journal of the Japan Society of Chemotherapy 2002; 8:99-102.
13.
Smeeth L, Cook C, Thomas S, Hall AJ, Hubbard R, Vallance P. Risk of deep vein thrombosis and pulmonary embolism after acute infection in a community setting. Lancet 2006; 367:1075-9.
14.
Diaz JA, Ramacciotti E, Wakefield TW. Do galectins play a role in venous thrombosis? a review. Thrombosis research 2010; 125:373-6.
15.
Jourdan A, Aguejouf O, Imbault P, Doutremepuich F, Inamo J, Doutremepuich C. Experimental thrombosis model induced by free radicals. Application to aspirin and other different substances. Thrombosis research 1995; 79:109-23.
16.
Keller TT, van der Sluijs KF, de Kruif MD, et al. Effects on coagulation and fibrinolysis induced by influenza in mice with a reduced capacity to generate activated protein C and a deficiency in plasminogen activator inhibitor type 1. Circulation Research 2006; 99:1261-9.
17.
Center for Disease Control and Prevention. Intensive-care patients with severe novel influenza A (H1N1) virus infection; Michigan June 2009. MMWR July 17 2009;58:749–52.
18.
Oboho IK, Reed C, Gargiullo P, et al. Benefit of Early Initiation of Influenza Antiviral Treatment to Pregnant Women Hospitalized With Laboratory-Confirmed Influenza. The Journal of Infectious Diseases 2016.
19.
Mauad T, Hajjar LA, Callegari GD, et al. Lung pathology in fatal novel human influenza A (H1N1) infection. American journal of respiratory and critical care medicine 2010; 181:72-9.
20.
Esteban A, Fernandez-Segoviano P, Frutos-Vivar F, et al. Comparison of clinical criteria for the acute respiratory distress syndrome with autopsy findings. Annals of Internal Medicine 2004; 141:440-5.
21.
Chan KH, Zhang AJ, To KK, et al. Wild type and mutant 2009 pandemic influenza A (H1N1) viruses cause more severe disease and higher mortality in pregnant BALB/c mice. PLoS One 2010; 5:e13757.
22.
Ona MA, Bashari DR, Tharayil Z, et al. A case of fatal fulminant myocarditis presenting as an acute ST-segment elevation myocardial infarction and persistent ventricular tachyarrhythmia associated with influenza A (H1N1) virus in a previously healthy pregnant woman. Cardiology 2012; 123:103-7.
23.
Kaulgud RS, Kamath V, Patil V, Desai S. Symmetric Peripheral Gangrene Associated with H1N1 Infection. International Journal of Preventive Medicine 2013; 4:1206-9.
24.
Bunce PE, High SM, Nadjafi M, Stanley K, Liles WC, Christian MD. Pandemic H1N1 influenza infection and vascular thrombosis. Clinical infectious diseases: an official publication of the Infectious Diseases Society of America 2011; 52:e14-7.
25.
Beurtheret S, Mastroianni C, Pozzi M, et al. Extracorporeal membrane oxygenation for 2009 influenza A (H1N1) acute respiratory distress syndrome: single-centre experience with 1-year follow-up. European journal of cardio-thoracic surgery: official journal of the European Association for Cardio-Thoracic Surgery 2012; 41:691-5.
26.
Gokce M, Unal S, Aytac S, et al. Is Swine-origin Influenza a Predisposing Factor for Deep Vein Thrombosis? Turkish journal of haematology: official journal of Turkish Society of Haematology 2012; 29:174-6.
27.
Dülger AC, Avcu S, Arslan H, et al. Pulmonary Embolism Associated with Pandemic H1N1 Influenza A Virus Infection: a Case Report. Balkan Med J 2011; 28:460-2.
28.
Lynn DJ, Wyman AC, Varma VM. Influenza A infection simulating pulmonary embolism. JAMA 1977; 238:1166-8.
29.
Matin P. Influenza A infection should not simulate pulmonary embolism. JAMA 1978; 239:725.
30.
Sebat CM, Albertson TE, Morrissey BM. Cerebral gas embolism in a case of Influenza A-associated acute respiratory distress syndrome treated with high-frequency oscillatory ventilation. Ann Thorac Med 2013; 8:124-6.
31.
Kristufkova A, Borovsky M, Korbel M, Knight M. Amniotic fluid embolism--investigation of fatal cases in Slovakia in the years 2005-2010 compared with fatal cases in the United Kingdom. Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub 2014; 158:397-403.
32.
Zhu T, Carcaillon L, Martinez I, et al. Association of influenza vaccination with reduced risk of venous thromboembolism. Thrombosis and Haemostasis 2009; 102:1259-64.
33.
Ciszewski A, Bilinska ZT, Brydak LB, et al. Influenza vaccination in secondary prevention from coronary ischaemic events in coronary artery disease: FLUCAD study. European Heart Journal 2008; 29:1350-8.